China Hematological Cancers Market Research Report 2018

China Hematological Cancers Market Research Report 2017

1 Hematological Cancers Overview

1.1 Product Overview and Scope of Hematological Cancers

1.2 Classification of Hematological Cancers by Product Category

1.2.1 China Hematological Cancers Sales (K Units) Comparison by Type (2012-2022)

1.2.2 China Hematological Cancers Sales (K Units) Market Share by Type in 2016

1.2.3 Pharmacological Therapies

1.2.4 Stem Cell Transplantation

1.2.5 Surgery and Radiation Therapy

1.2.6 Anemia Treatment

1.2.7 Thrombosis Treatment

1.2.8 Neutopenia Treatment

1.2.9 Symptomatic treatment

1.3 China Hematological Cancers Market by Application/End Users

1.3.1 China Hematological Cancers Sales (K Units) and Market Share Comparison by Applications (2012-2022)

1.3.2 Epidemiology

1.3.3 Pathophysiology of Leukemic Stem Cells

1.3.4 Kidney Diseases

1.3.5 Genetic Diseases

1.3.6 Other Diseases

1.4 China Hematological Cancers Market by Region

1.4.1 China Hematological Cancers Market Size (Million USD) Comparison by Region (2012-2022)

1.4.2 South China Hematological Cancers Status and Prospect (2012-2022)

1.4.3 East China Hematological Cancers Status and Prospect (2012-2022)

1.4.4 Southwest China Hematological Cancers Status and Prospect (2012-2022)

1.4.5 Northeast China Hematological Cancers Status and Prospect (2012-2022)

1.4.6 North China Hematological Cancers Status and Prospect (2012-2022)

1.4.7 Central China Hematological Cancers Status and Prospect (2012-2022)

1.5 China Market Size (Sales and Revenue) of Hematological Cancers (2012-2022)

1.5.1 China Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2022)

1.5.2 China Hematological Cancers Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Hematological Cancers Market Competition by Players/Manufacturers

2.1 China Hematological Cancers Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2 China Hematological Cancers Revenue and Share by Players/Manufacturers (2012-2017)

2.3 China Hematological Cancers Average Price (USD/Unit) by Players/Manufacturers (2012-2017)

2.4 China Hematological Cancers Market Competitive Situation and Trends

2.4.1 China Hematological Cancers Market Concentration Rate

2.4.2 China Hematological Cancers Market Share of Top 3 and Top 5 Players/Manufacturers

2.4.3 Mergers & Acquisitions, Expansion in China Market

2.5 China Players/Manufacturers Hematological Cancers Manufacturing Base Distribution, Sales Area, Product Types

3 China Hematological Cancers Sales and Revenue by Region (2012-2017)

3.1 China Hematological Cancers Sales (K Units) and Market Share by Region (2012-2017)

3.2 China Hematological Cancers Revenue (Million USD) and Market Share by Region (2012-2017)

3.3 China Hematological Cancers Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"

4.1 China Hematological Cancers Sales (K Units) and Market Share by Type/ Product Category (2012-2017)

4.2 China Hematological Cancers Revenue (Million USD) and Market Share by Type (2012-2017)

4.3 China Hematological Cancers Price (USD/Unit) by Type (2012-2017)

4.4 China Hematological Cancers Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"

5.1 China Hematological Cancers Sales (K Units) and Market Share by Application (2012-2017)

5.2 China Hematological Cancers Sales Growth Rate (%) by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 China Hematological Cancers Players/Suppliers Profiles and Sales Data

6.1 Karyopharm Therapeutics

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Hematological Cancers Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Karyopharm Therapeutics Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.1.4 Main Business/Business Overview

6.2 Johnson & Johnson

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Hematological Cancers Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Johnson & Johnson Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.2.4 Main Business/Business Overview

6.3 Roche Diagnostics A/S

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Hematological Cancers Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Roche Diagnostics A/S Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.3.4 Main Business/Business Overview

6.4 AbbVie

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Hematological Cancers Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 AbbVie Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.4.4 Main Business/Business Overview

6.5 Novartis

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Hematological Cancers Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Novartis Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.5.4 Main Business/Business Overview

6.6 Kite Pharma

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Hematological Cancers Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Kite Pharma Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.6.4 Main Business/Business Overview

6.7 Celgene Corporation

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Hematological Cancers Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Celgene Corporation Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.7.4 Main Business/Business Overview

6.8 Abbott Laboratories

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Hematological Cancers Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Abbott Laboratories Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.8.4 Main Business/Business Overview

6.9 Beckman Coulter

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Hematological Cancers Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Beckman Coulter Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.9.4 Main Business/Business Overview

6.10 HemoCue AB

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Hematological Cancers Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 HemoCue AB Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.10.4 Main Business/Business Overview

6.11 C. R. Bard

6.12 Siemens AG

6.13 Sysmex

6.14 Mindray Medical International Limited

6.15 Bio-Rad Laboratories

6.16 The Medicine Company

6.17 Pharmacyclics

6.18 Horiba

6.19 DiagnoCure Inc.

6.20 Astellas Pharma US

7 Hematological Cancers Manufacturing Cost Analysis

7.1 Hematological Cancers Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Hematological Cancers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Hematological Cancers Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Hematological Cancers Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Hematological Cancers Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 China Hematological Cancers Sales (K Units), Revenue (Million USD) Forecast (2017-2022)

11.2 China Hematological Cancers Sales (K Units) Forecast by Type (2017-2022)

11.3 China Hematological Cancers Sales (K Units) Forecast by Application (2017-2022)

11.4 China Hematological Cancers Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Figure Global and China Market Size (Million USD) Comparison (2012-2022)

Table Hematological Cancers Sales (K Units) and Revenue (Million USD) Market Split by Product Type

Table Hematological Cancers Sales (K Units) by Application (2016-2022)

Figure Product Picture of Hematological Cancers

Table China Hematological Cancers Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)

Figure China Hematological Cancers Sales Volume Market Share by Types in 2016

Figure Pharmacological Therapies Product Picture

Figure Stem Cell Transplantation Product Picture

Figure Surgery and Radiation Therapy Product Picture

Figure Anemia Treatment Product Picture

Figure Thrombosis Treatment Product Picture

Figure Neutopenia Treatment Product Picture

Figure Symptomatic treatment Product Picture

Figure China Hematological Cancers Sales (K Units) Comparison by Application (2012-2022)

Figure China Sales Market Share (%) of Hematological Cancers by Application in 2016

Figure Epidemiology Examples

Table Key Downstream Customer in Epidemiology

Figure Pathophysiology of Leukemic Stem Cells Examples

Table Key Downstream Customer in Pathophysiology of Leukemic Stem Cells

Figure Kidney Diseases Examples

Table Key Downstream Customer in Kidney Diseases

Figure Genetic Diseases Examples

Table Key Downstream Customer in Genetic Diseases

Figure Other Diseases Examples

Table Key Downstream Customer in Other Diseases

Figure South China Hematological Cancers Revenue (Million USD) and Growth Rate (2012-2022)

Figure East China Hematological Cancers Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest China Hematological Cancers Revenue (Million USD) and Growth Rate (2012-2022)

Figure Northeast China Hematological Cancers Revenue (Million USD) and Growth Rate (2012-2022)

Figure North China Hematological Cancers Revenue (Million USD) and Growth Rate (2012-2022)

Figure Central China Hematological Cancers Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2022)

Figure China Hematological Cancers Revenue (Million USD) and Growth Rate (%)(2012-2022)

Table China Hematological Cancers Sales of Key Players/Manufacturers (2012-2017)

Table China Hematological Cancers Sales Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Hematological Cancers Sales Share (%) by Players/Manufacturers

Figure 2017 China Hematological Cancers Sales Share (%) by Players/Manufacturers

Table China Hematological Cancers Revenue by Players/Manufacturers (2012-2017)

Table China Hematological Cancers Revenue Market Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Hematological Cancers Revenue Market Share (%) by Players/Manufacturers

Figure 2017 China Hematological Cancers Revenue Market Share (%) by Players/Manufacturers

Table China Market Hematological Cancers Average Price of Key Players/Manufacturers (2012-2017)

Figure China Market Hematological Cancers Average Price of Key Players/Manufacturers in 2016

Figure China Hematological Cancers Market Share of Top 3 Players/Manufacturers

Figure China Hematological Cancers Market Share of Top 5 Players/Manufacturers

Table China Players/Manufacturers Hematological Cancers Manufacturing Base Distribution and Sales Area

Table China Players/Manufacturers Hematological Cancers Product Category

Table China Hematological Cancers Sales (K Units) by Regions (2012-2017)

Table China Hematological Cancers Sales Share (%) by Regions (2012-2017)

Figure China Hematological Cancers Sales Share (%) by Regions (2012-2017)

Figure China Hematological Cancers Sales Market Share (%) by Regions in 2016

Table China Hematological Cancers Revenue (Million USD) and Market Share by Regions (2012-2017)

Table China Hematological Cancers Revenue Market Share (%) by Regions (2012-2017)

Figure China Hematological Cancers Revenue Market Share (%) by Regions (2012-2017)

Figure China Hematological Cancers Revenue Market Share (%) by Regions in 2016

Table China Hematological Cancers Price (USD/Unit) by Regions (2012-2017)

Table China Hematological Cancers Sales (K Units) by Type (2012-2017)

Table China Hematological Cancers Sales Share (%) by Type (2012-2017)

Figure China Hematological Cancers Sales Share (%) by Type (2012-2017)

Figure China Hematological Cancers Sales Market Share (%) by Type in 2016

Table China Hematological Cancers Revenue (Million USD) and Market Share by Type (2012-2017)

Table China Hematological Cancers Revenue Market Share (%) by Type (2012-2017)

Figure Revenue Market Share of Hematological Cancers by Type (2012-2017)

Figure Revenue Market Share of Hematological Cancers by Type in 2016

Table China Hematological Cancers Price (USD/Unit) by Types (2012-2017)

Figure China Hematological Cancers Sales Growth Rate (%) by Type (2012-2017)

Table China Hematological Cancers Sales (K Units) by Applications (2012-2017)

Table China Hematological Cancers Sales Market Share (%) by Applications (2012-2017)

Figure China Hematological Cancers Sales Market Share (%) by Application (2012-2017)

Figure China Hematological Cancers Sales Market Share (%) by Application in 2016

Table China Hematological Cancers Sales Growth Rate (%) by Application (2012-2017)

Figure China Hematological Cancers Sales Growth Rate (%) by Application (2012-2017)

Table Karyopharm Therapeutics Hematological Cancers Basic Information List

Table Karyopharm Therapeutics Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Karyopharm Therapeutics Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Karyopharm Therapeutics Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Karyopharm Therapeutics Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table Johnson & Johnson Hematological Cancers Basic Information List

Table Johnson & Johnson Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Johnson & Johnson Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Johnson & Johnson Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Johnson & Johnson Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table Roche Diagnostics A/S Hematological Cancers Basic Information List

Table Roche Diagnostics A/S Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Roche Diagnostics A/S Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Roche Diagnostics A/S Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Roche Diagnostics A/S Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table AbbVie Hematological Cancers Basic Information List

Table AbbVie Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure AbbVie Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure AbbVie Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure AbbVie Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table Novartis Hematological Cancers Basic Information List

Table Novartis Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Novartis Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Novartis Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Novartis Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table Kite Pharma Hematological Cancers Basic Information List

Table Kite Pharma Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Kite Pharma Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Kite Pharma Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Kite Pharma Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table Celgene Corporation Hematological Cancers Basic Information List

Table Celgene Corporation Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Celgene Corporation Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Celgene Corporation Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Celgene Corporation Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table Abbott Laboratories Hematological Cancers Basic Information List

Table Abbott Laboratories Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Abbott Laboratories Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Abbott Laboratories Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Abbott Laboratories Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table Beckman Coulter Hematological Cancers Basic Information List

Table Beckman Coulter Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Beckman Coulter Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Beckman Coulter Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure Beckman Coulter Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table HemoCue AB Hematological Cancers Basic Information List

Table HemoCue AB Hematological Cancers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure HemoCue AB Hematological Cancers Sales (K Units) and Growth Rate (%)(2012-2017)

Figure HemoCue AB Hematological Cancers Sales Market Share (%) in China (2012-2017)

Figure HemoCue AB Hematological Cancers Revenue Market Share (%) in China (2012-2017)

Table C. R. Bard Hematological Cancers Basic Information List

Table Siemens AG Hematological Cancers Basic Information List

Table Sysmex Hematological Cancers Basic Information List

Table Mindray Medical International Limited Hematological Cancers Basic Information List

Table Bio-Rad Laboratories Hematological Cancers Basic Information List

Table The Medicine Company Hematological Cancers Basic Information List

Table Pharmacyclics Hematological Cancers Basic Information List

Table Horiba Hematological Cancers Basic Information List

Table DiagnoCure Inc. Hematological Cancers Basic Information List

Table Astellas Pharma US Hematological Cancers Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Hematological Cancers

Figure Manufacturing Process Analysis of Hematological Cancers

Figure Hematological Cancers Industrial Chain Analysis

Table Raw Materials Sources of Hematological Cancers Major Players/Manufacturers in 2016

Table Major Buyers of Hematological Cancers

Table Distributors/Traders List

Figure China Hematological Cancers Sales (K Units) and Growth Rate (%) Forecast (2017-2022)

Figure China Hematological Cancers Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Hematological Cancers Price (USD/Unit) Trend Forecast (2017-2022)

Table China Hematological Cancers Sales (K Units) Forecast by Type (2017-2022)

Figure China Hematological Cancers Sales (K Units) Forecast by Type (2017-2022)

Figure China Hematological Cancers Sales Volume Market Share Forecast by Type in 2022

Table China Hematological Cancers Sales (K Units) Forecast by Application (2017-2022)

Figure China Hematological Cancers Sales Volume Market Share Forecast by Application (2017-2022)

Figure China Hematological Cancers Sales Volume Market Share Forecast by Application in 2022

Table China Hematological Cancers Sales (K Units) Forecast by Regions (2017-2022)

Table China Hematological Cancers Sales Volume Share Forecast by Regions (2017-2022)

Figure China Hematological Cancers Sales Volume Share Forecast by Regions (2017-2022)

Figure China Hematological Cancers Sales Volume Share Forecast by Regions in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources